Albert Power

Albert Power is a Senior Lecturer at the University of Bristol and an Honorary Senior Clinical Lecturer in Renal Medicine at Imperial College London. He also serves as a Consultant Nephrologist at North Bristol NHS Trust (NBT) since March 2014.

His research focuses on Nephrology, particularly Chronic Kidney Disease, Hemodialysis, and Cerebrovascular Accidents, with significant work on catheter-related complications and disease progression.

Recent publications highlight his contributions to clinical trials in IgA Nephropathy (e.g., Atacicept studies) and Chronic Kidney Disease (e.g., EMPA-KIDNEY Collaborative Group). Keywords from his work include B-cell therapy, Albumin-to-Creatinine ratio, and Glomerular Filtration Rate.

• Prizes:
  • Competitive Call for EURODOPPS Project Proposals (2015)
• Advisory Roles:
  • NHS England (2023–present)
  • NHS England South West (2021–present)
• Projects:
  • Co-Principal Investigator on "How does starting haemodialysis affect brain, bladder and eye health?"